These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 548990)

  • 1. Plasma inhibitors of the erythrocyte hexose monophosphate shunt in uraemia.
    Zingraff J; Kamoun P; Lebreton P; Drüeke T; Man NK; Jungers P
    Proc Eur Dial Transplant Assoc; 1979; 16():475-80. PubMed ID: 548990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ascorbate-cyanide test on red blood cells in uremia: effect of guanidinopropionic acid.
    Kamoun PP; Zingraff JJ; Turlin G; Lebreton P
    Nephron; 1981; 28(1):26-9. PubMed ID: 7266724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anemia of renal failure: the role of the hexose monophosphate shunt.
    Tet-Ken-Voo R
    Can J Med Technol; 1973 Oct; 35(5):14 passim. PubMed ID: 4756807
    [No Abstract]   [Full Text] [Related]  

  • 4. Improvement of insulin binding to erythrocyte insulin receptors in uraemia by haemodialysis.
    Milutinović S; Breyer D; Janković M; Stefović A; Molnar V; Mrzljak V; Rocić B
    Proc Eur Dial Transplant Assoc; 1983; 19():763-8. PubMed ID: 6348765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of uraemia-induced decrease in insulin binding on erythrocytes.
    Marttinen A; Pasternack A; Koivula T
    Nephrol Dial Transplant; 1987; 2(4):233-7. PubMed ID: 3118263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red cell hexosemonophosphate shunt deficiency in uremia.
    Jacob H; Yawata Y; Howe R
    Adv Exp Med Biol; 1972; 28():133-43. PubMed ID: 5085165
    [No Abstract]   [Full Text] [Related]  

  • 7. Lecithin: cholesterol acyltransfer, dyslipoproteinaemia and membrane lipids in uraemia.
    Gillett MP; Obineche EN; El-Rokhaimi M; Lakhani MS; Abdulle A; Sulaiman M
    J Nephrol; 2001; 14(6):472-80. PubMed ID: 11783603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SEM studies of erythrocyte shape as an indicator of erythrocyte function.
    Dardano JR; Kimzey SL
    Scan Electron Microsc; 1979; (3):809-14, 800. PubMed ID: 524049
    [No Abstract]   [Full Text] [Related]  

  • 9. [Uremic plasma as cause of metabolic changes in red blood cells].
    Eggert W; Schmidt G; Devaux S
    Z Urol Nephrol; 1981 Feb; 74(2):141-7. PubMed ID: 7223096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairment of glutathione biosynthetic pathway in uraemia and dialysis.
    Alhamdani MS
    Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative injury to erythrocytes, cell rigidity, and splenic hemolysis in hemodialyzed uremic patients.
    Rosenmund A; Binswanger U; Straub PW
    Ann Intern Med; 1975 Apr; 82(4):460-5. PubMed ID: 1119763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microcalorimetric measurements of heat production in erythrocytes of patients with chronic uraemia.
    Monti M
    Scand J Haematol; 1977 Feb; 18(2):154-62. PubMed ID: 841271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The presence and toxicity of guanidinoproprionic acid in uremia.
    Shainkin R; Giatt Y; Berlyne GM
    Kidney Int Suppl; 1975 Feb; (3):302-5. PubMed ID: 1057703
    [No Abstract]   [Full Text] [Related]  

  • 14. Chloramines, an aggravating factor in the anemia of patients on regular dialysis treatment.
    Botella J; Traver JA; Sanz-Guajardo D; Torres MT; Sanjuan I; Zabala P
    Proc Eur Dial Transplant Assoc; 1977; 14():192-9. PubMed ID: 600956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron absorption in patients with chronic uraemia. A comparative study using whole body counting and red cell incorporation of radioiron.
    Milman N
    Scand J Haematol; 1982 Jul; 29(1):5-17. PubMed ID: 6812212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentose-phosphate shunt activity and red blood cell malonyldialdehyde levels in haemodialysis and in CAPD patients.
    Taccone-Gallucci M; Giardini O; Lubrano R; Mazzarella V; Bandino D; Meloni C; Elli M; Citti F; Cozzari M; Buoncristiani U
    Life Support Syst; 1985; 3 Suppl 1():121-4. PubMed ID: 3870550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal red cell metabolism in patients with chronic uremia: Nature of the defect and its persistence despite adequate hemodialysis.
    Yawata Y; Jacob HS
    Blood; 1975 Feb; 45(2):231-9. PubMed ID: 235337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma vitamin E levels in a chronically hemolyzing group of dialysis patients.
    Cohen JD; Viljoen M; Clifford D; De Oliveria AA; Veriava Y; Milne FJ
    Clin Nephrol; 1986 Jan; 25(1):42-7. PubMed ID: 3955908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression of glucose transporter 1 on erythrocyte membrane in hemodialysis patients: the possible role in erythrocyte ascorbate recycling.
    Wann JG; Lin CS; Chang LC; Hsu YH; Chien CT; Tai DW; Chen JS; Yang CC; Yeung LK; Chen CF
    Am J Kidney Dis; 2006 Jun; 47(6):1055-63. PubMed ID: 16731301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function.
    Sardenberg C; Suassuna P; Andreoli MC; Watanabe R; Dalboni MA; Manfredi SR; dos Santos OP; Kallas EG; Draibe SA; Cendoroglo M
    Nephrol Dial Transplant; 2006 Jan; 21(1):160-5. PubMed ID: 16155068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.